rwj-445380
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2006 (NCT00396422)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Cathepsin SINHIBITOR
CTSS inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rwj-445380
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00425321 | Phase 2 | Dec 1, 2006 | Johnson and Johnson |
| NCT00396422 | Phase 2 | Sep 1, 2006 | Alza |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alza | For profit | 1 | 1 | 1 | 2006 |
| Johnson and Johnson | For profit | 1 | 1 | 1 | 2006 |
2 organizations
Page 1 / 1